Skip to main content

Advertisement

Erratum to: ENOX2-based early detection (ONCOblot) of asbestos-induced malignant mesothelioma 4–10 years in advance of clinical symptoms

The original article was published in Clinical Proteomics 2016 13:2

Erratum to: Clin Proteom (2016) 13:2 DOI 10.1186/s12014-016-9103-3

It has come to the publisher’s attention that the original version of this article [1] unfortunately contained an unnecessarily complicated version of the data in Table 1. This Erratum replaces Table 1 of the original article with the table below.

Table 1 Range of molecular weights and isoelectric points (99th percentile) of ENOX2 transcript variants for 16 common cancer types compared with mesothelioma [Unpublished data from the ONCOblot Tissue of Origin Database, MorNuCo, Inc]

Reference

  1. 1.

    Morré DJ, Hostetler B, Taggart DJ, Morré DM, Musk AW, Robinson BWS, Creaney J. ENOX2-based early detection (ONCOblot) of asbestos-induced malignant mesothelioma 4–10 years in advance of clinical symptoms. Clin Proteom. 2016;13:2.

Download references

Author information

Correspondence to D. James Morré.

Additional information

The online version of the original article can be found under doi:10.1186/s12014-016-9103-3.

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark